UBS Group
MEDS icon

UBS Group’s DataMeds AI MEDS Stock Holding History

UBS Group’s Portfolio MEDS Stock Details MEDS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$31.4K Buy
+9,914
New +$24.2K ﹤0.01% 8064
2026
Q1 		– Sell
-319
Closed -$6.37K – 11527
2025
Q4 		$6.37K Sell
319
-534
-63% -$15.7K ﹤0.01% 8559
2025
Q3 		$37.8K Buy
+853
New +$45K ﹤0.01% 7758
2025
Q2 		– Sell
-59
Closed -$12.8K – 11118
2025
Q1 		$12.8K Buy
+59
New +$10K ﹤0.01% 8479

Other funds holding MEDS

OneDigital Investment Advisors
OneDigital Investment Advisors Overland Park, Kansas $12.7B AUM 13.94% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Fortitude Family Office
Fortitude Family Office Scottsdale, Arizona $586M AUM 20.58% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
Global Retirement Partners
Global Retirement Partners San Rafael, California $7.1B AUM
Caitong International Asset Management
Caitong International Asset Management Hong Kong $1.04B AUM 150.26% 1-Year Est. Return
Danske Bank
Danske Bank Copenhagen K, Denmark $50.1B AUM 35.17% 1-Year Est. Return

UBS Group's MEDS Position: Q3 2026 in Review

UBS Group opened a new position in DataMeds AI (MEDS) in Q3 2026: 9,914 shares worth $31.4K. The stake represents ﹤0.01% of the portfolio and ranks #8064 among its holdings. This is a return to the name: UBS Group previously reported a position in MEDS as recently as Q4 2025.

UBS Group first reported a position in MEDS in Q1 2025 and has held it in 4 quarters since. The position peaked at $37.8K in Q3 2025. 10 funds tracked by Wall St. Rank hold MEDS as of Q3 2026.

  • UBS Group held 9,914 shares of DataMeds AI worth $31.4K as of Q3 2026.
  • DataMeds AI was a new UBS Group position in Q3 2026.
  • DataMeds AI made up ﹤0.01% of UBS Group's portfolio in Q3 2026, its #8064 holding.
  • UBS Group first reported a position in DataMeds AI in Q1 2025 and has held it in 4 quarters since.
  • UBS Group's DataMeds AI position peaked at $37.8K in Q3 2025.
  • 10 funds tracked by Wall St. Rank held DataMeds AI as of Q3 2026.

Based on UBS Group's 13F filing for Q3 2026, filed 10 Nov 2026.